RespireRx Pharmaceuticals Top Insiders

RSPIDelisted Stock  USD 0.01  0.00  0.00%   
RespireRx Pharmaceuticals employs about 2 people. The company is managed by 6 executives with a total tenure of roughly 18 years, averaging almost 3.0 years of service per executive, having 0.33 employees per reported executive. Assessment of RespireRx Pharmaceuticals' management performance can provide insight into the firm performance.
Arnold Lippa  Chairman
Executive Chairman and Chief Scientific Officer
Richard Purcell  President
Senior Vice President - Research and Development
  
Check out Your Equity Center to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in american community survey.

RespireRx Pharmaceuticals Management Team Effectiveness

The company has return on total asset (ROA) of (8.3401) % which means that it has lost $8.3401 on every $100 spent on assets. This is way below average. RespireRx Pharmaceuticals' management efficiency ratios could be used to measure how well RespireRx Pharmaceuticals manages its routine affairs as well as how well it operates its assets and liabilities.

RespireRx Pharmaceuticals Workforce Comparison

RespireRx Pharmaceuticals is rated below average in number of employees category among its peers. The total workforce of Health Care industry is at this time estimated at about 25,953. RespireRx Pharmaceuticals adds roughly 2.0 in number of employees claiming only tiny portion of equities under Health Care industry.

RespireRx Pharmaceuticals Notable Stakeholders

A RespireRx Pharmaceuticals stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as RespireRx Pharmaceuticals often face trade-offs trying to please all of them. RespireRx Pharmaceuticals' stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting RespireRx Pharmaceuticals' stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
Arnold LippaExecutive Chairman and Chief Scientific OfficerProfile
Richard PurcellSenior Vice President - Research and DevelopmentProfile
Jeff MargolisVP, Treasurer, Secretary and DirectorProfile
Arvid CarlssonConsultantProfile
David DickasonVP DevelProfile
Marc RadinControllerProfile

About RespireRx Pharmaceuticals Management Performance

The success or failure of an entity such as RespireRx Pharmaceuticals often depends on how effective the management is. RespireRx Pharmaceuticals management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of RespireRx management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the RespireRx management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
RespireRx Pharmaceuticals Inc. engages in the discovery, development, and commercialization of pharmaceuticals for the treatment of neurological and psychiatric disorders. RespireRx Pharmaceuticals Inc. was incorporated in 1987 and is headquartered in Glen Rock, New Jersey. Respirerx Pharmaceuticals operates under Biotechnology classification in the United States and is traded on OTC Exchange. It employs 2 people.

RespireRx Pharmaceuticals Workforce Analysis

Traditionally, organizations such as RespireRx Pharmaceuticals use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare RespireRx Pharmaceuticals within its industry.

RespireRx Pharmaceuticals Manpower Efficiency

Return on RespireRx Pharmaceuticals Manpower

Revenue Per Employee0.0
Revenue Per Executive0.0
Net Loss Per Employee1.6M
Net Loss Per Executive524.1K
Check out Your Equity Center to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in american community survey.
You can also try the AI Portfolio Architect module to use AI to generate optimal portfolios and find profitable investment opportunities.

Other Consideration for investing in RespireRx Pink Sheet

If you are still planning to invest in RespireRx Pharmaceuticals check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the RespireRx Pharmaceuticals' history and understand the potential risks before investing.
Watchlist Optimization
Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm
Premium Stories
Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope
Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
Global Markets Map
Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes
Latest Portfolios
Quick portfolio dashboard that showcases your latest portfolios
Price Exposure Probability
Analyze equity upside and downside potential for a given time horizon across multiple markets
Fundamentals Comparison
Compare fundamentals across multiple equities to find investing opportunities
Bonds Directory
Find actively traded corporate debentures issued by US companies
Portfolio Dashboard
Portfolio dashboard that provides centralized access to all your investments